ArticleBMC ophthalmology2025
A comparative analysis of the 1-year outcomes of modified Athens protocol versus Cretan protocol in the treatment of progressive keratoconus.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis retrospective comparative cohort study aimed to compare the one-year outcomes of two modified surgical protocols, the Athens protocol followed by accelerated corneal cross-linking (ACXL) (topography-guided transepithelial photorefractive keratectomy [TG-TPRK] combined with ACXL) and the Cretan protocol followed by ACXL (transepithelial phototherapeutic keratectomy [TPTK] combined with ACXL), in patients with progressive keratoconus.
methodsThe study included 92 eyes of 67 patients (49 eyes/34 patients in the TG-TPRK-ACXL group; 43 eyes/33 patients in the TPTK-ACXL group). According to the TG-TPRK-ACXL ablation plan, TPTK was conducted on patients with a projected postoperative thinnest corneal thickness (TCT) of less than 400 μm. Visual acuity, refractive status, keratometry readings, corneal thickness, and keratoconus parameters were assessed preoperatively and 1-year postoperatively. Intraoperative ablation depth was also recorded. Generalized estimating equations (GEE) were applied to adjust for baseline characteristics and to compare the differences in ocular characteristic changes between the two groups after 1 year.
resultsBoth groups showed significant improvement in uncorrected and best spectacle-corrected distance visual acuity (UDVA and BCVA) as well as a reduction in postoperative corneal curvature and irregularity index. After GEE correction, the TPTK-ACXL group showed a greater increase in BCVA (β = -0.117, P = 0.002). There were no significant variances between the two groups regarding changes in refractive error, corneal curvature, corneal astigmatism, and keratoconus parameters. Central and maximum ablation depths were thinner in the TPTK-ACXL group than in the TG-TPRK-ACXL group (P < 0.001). No serious intraoperative or postoperative complications were reported.
conclusionsBoth TPTK-ACXL and TG-TPRK-ACXL treatments have demonstrated efficacy in improving visual acuity and corneal regularity among keratoconus patients at the 1-year follow-up. TPTK-ACXL may be particularly beneficial for patients with poorer corneal conditions, potentially minimizing corneal thickness loss and serving as a substitute for TG-TPRK-ACXL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.